Skip to main content
. 2020 Aug 15;78(12):2138–2146. doi: 10.1016/j.joms.2020.08.012

Figure 3.

Figure 3

Radiographic analysis, osteoclast counting, and the number of interleukin (IL)-6 positive cells in dental alveoli three days after exodontia and treatment with varying doses of tocilizumab (TCZ) showing no radiographic alterations, reduction in osteoclasts counting, and increase in the number of IL-6 immunostained cells. ∗P < .05 versus sham group; P < .05 versus saline group; (ANOVA/Bonferroni, data presented as mean ± standard error; n = 6/group). Original magnification × 400.